GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against solid tumors and infectious diseases, announced today that the U.S. Patent and ...

For instance, oral vaccines could allow repeat dosing without a treatment-limiting anti-vector response – where ... and cell therapies for cancer and infectious diseases.

Good morning and thank you for joining Amneal Pharmaceuticals first quarter 2025 earnings call. Today, we issued a press ...

Choose from Colorectal Cancer Icon stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Plans and pricing ...

Novo Nordisk has had its NDA for an oral formulation of Wegovy accepted by the FDA. It would be the first obesity-targeted GLP-1 in pill form. Italfarmaco's oral HDAC inhibitor Duvyzat has been ...

Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related deaths, and early detection is key to improving ...

Watch WXII's Jackie Pascale's full interview with oral medicine specialist Dr. Shaiba Sandhu in the video player above to hear about the life-saving treatment many cancer patients need before they ...

Preliminary results from the AACR 2025 Annual Meeting reveal encouraging clinical responses to the investigational oral agent ...

Three students from Bentonville West High School are being recognized on the national stage for transforming a smartphone ...

Tongue cancer makes up less than 1 percent of new cancer diagnoses in the U.S., according to The Oral Cancer Foundation. Though it remains among the most common type of head or neck cancer ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a ...